Treace Medical Concepts (TMCI) Total Current Liabilities (2020 - 2026)
Treace Medical Concepts (TMCI) posted Total Current Liabilities of $34.5 million for Q1 2026, up 12.59% on a QoQ basis from $30.6 million in Q4 2025, and up 3.95% year-over-year from $33.2 million in Q1 2025.
Treace Medical Concepts (TMCI) Total Current Liabilities (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $34.5 million for Q1 2026.
- Quarterly Total Current Liabilities rose 3.95% year-over-year to $34.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.5 million (up 3.95% YoY) and the FY2025 annual result came in at $30.6 million, down 12.28% from the prior year.
- Total Current Liabilities was $34.5 million for Q1 2026 at Treace Medical Concepts, up from $30.6 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $47.0 million in Q1 2024 and bottomed at $15.4 million in Q1 2022.
- A 5-year average of $33.1 million and a median of $33.2 million in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 110.58% — and 2025, when it retreated 29.48%.
- Treace Medical Concepts' Total Current Liabilities stood at $30.2 million in 2022, then jumped by 48.89% to $45.0 million in 2023, then retreated by 22.45% to $34.9 million in 2024, then declined by 12.28% to $30.6 million in 2025, then advanced by 12.59% to $34.5 million in 2026.
- Business Quant data shows TMCI's Total Current Liabilities at $34.5 million in Q1 2026, $30.6 million in Q4 2025, and $40.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | 34.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.49 Mn |
| Dec 31, 2025 | 30.64 Mn |
| Sep 30, 2025 | 40.91 Mn |
| Jun 30, 2025 | 41.90 Mn |
| Mar 31, 2025 | 33.18 Mn |
| Dec 31, 2024 | 34.93 Mn |
| Sep 30, 2024 | 38.26 Mn |
| Jun 30, 2024 | 44.45 Mn |
| Mar 31, 2024 | 47.05 Mn |
| Dec 31, 2023 | 45.03 Mn |
| Sep 30, 2023 | 33.15 Mn |
| Jun 30, 2023 | 30.02 Mn |
| Mar 31, 2023 | 23.30 Mn |
| Dec 31, 2022 | 30.25 Mn |
| Sep 30, 2022 | 22.58 Mn |
| Jun 30, 2022 | 16.64 Mn |
| Mar 31, 2022 | 15.38 Mn |
| Dec 31, 2021 | 18.21 Mn |
| Sep 30, 2021 | 10.72 Mn |
| Jun 30, 2021 | 9.87 Mn |